Pulmonary Arterial Hypertension in France

Легочная артериальная гипертензия во Франции
Marc J.C. Humbert, Gilbert Habib, Eric HACHULLA, Martine Reynaud‐Gaubert, Jean-François Cordier, Gérald Simonneau, Olivier Sitbon, Ari Chaouat, M. Bertocchi, Virginie Gressin, Azzedine Yaïci, Emmanuel Weitzenblum, F. Chabot, Claire Dromer, Christophe M. Pison, A. Haloun, Marcel Laurent
2006-02-02

PAHhemodynamic parametersprevalencepulmonary arterial hypertensionregistry
RATIONALE: Pulmonary arterial hypertension (PAH) is an orphan disease for which the trend is for management in designated centers with multidisciplinary teams working in a shared-care approach. OBJECTIVE: To describe clinical and hemodynamic parameters and to provide estimates for the prevalence of patients diagnosed for PAH according to a standardized definition. METHODS: The registry was initiated in 17 university hospitals following at least five newly diagnosed patients per year. All consecutive adult (> or = 18 yr) patients seen between October 2002 and October 2003 were to be included. MAIN RESULTS: A total of 674 patients (mean +/- SD age, 50 +/- 15 yr; range, 18-85 yr) were entered in the registry. Idiopathic, familial, anorexigen, connective tissue diseases, congenital heart diseases, portal hypertension, and HIV-associated PAH accounted for 39.2, 3.9, 9.5, 15.3, 11.3, 10.4, and 6.2% of the population, respectively. At diagnosis, 75% of patients were in New York Heart Association functional class III or IV. Six-minute walk test was 329 +/- 109 m. Mean pulmonary artery pressure, cardiac index, and pulmonary vascular resistance index were 55 +/- 15 mm Hg, 2.5 +/- 0.8 L/min/m(2), and 20.5 +/- 10.2 mm Hg/L/min/m(2), respectively. The low estimates of prevalence and incidence of PAH in France were 15.0 cases/million of adult inhabitants and 2.4 cases/million of adult inhabitants/yr. One-year survival was 88% in the incident cohort. CONCLUSIONS: This contemporary registry highlights current practice and shows that PAH is detected late in the course of the disease, with a majority of patients displaying severe functional and hemodynamic compromise.
1
At diagnosis, 75% of patients were in NYHA functional class III or IV, indicating late detection with severe symptoms.
2
Baseline six-minute walk distance averaged 329 ± 109 m; mean pulmonary artery pressure 55 ± 15 mm Hg; cardiac index 2.5 ± 0.8 L/min/m²; pulmonary vascular resistance index 20.5 ± 10.2 mm Hg·L⁻¹·min·m².
3
Estimated prevalence 15.0 cases per million adults and incidence 2.4 cases per million adults per year in France; one-year survival in incident cohort was 88%.
4
Etiology distribution: idiopathic 39.2%, familial 3.9%, anorexigen-associated 9.5%, connective tissue disease 15.3%, congenital heart disease 11.3%, portal hypertension 10.4%, HIV-associated 6.2%.
5
Registry included 674 adult PAH patients (mean age 50 ± 15 years) from 17 French university hospitals.

Adult patients diagnosed with pulmonary arterial hypertension (PAH) in France enrolled in a multicenter registry

Clinical, functional and hemodynamic characteristics, prevalence and incidence estimates, and 1-year survival of the diagnosed PAH patient population

Publication Details
Publication Date
2006-02-02
Journal
Publisher
ISSN
Cited by
2031
Access Type
Author Information
Authors
Marc J.C. Humbert
Gilbert Habib
Eric HACHULLA
Martine Reynaud‐Gaubert
Jean-François Cordier
Gérald Simonneau
Olivier Sitbon
Ari Chaouat
M. Bertocchi
Virginie Gressin
Azzedine Yaïci
Emmanuel Weitzenblum
F. Chabot
Claire Dromer
Christophe M. Pison
A. Haloun
Marcel Laurent
Explore further
Open the scid.ai AI chat with a ready-made request: it will find papers on a similar topic and help build a literature review.
Find similar papers in the chat →
Make a presentation
100%